EFPIA - NEWSLETTER

Trouble reading this email? View it in your browser


		EFPIA Newsletter 5 June 2025

News

EU Council’s decision on pharmaceutical legislation: A missed opportunity for European innovation...
04 June 2025

EFPIA's reaction to the GPL announcement from the EU Council of Ministers Read more

Blogs

Health as a strategic investment: Highlights from the 14th Value of Innovation Conference (Guest...
04 June 2025 - Barbara Stegel

What if we stopped seeing health as a cost and started treating it as a long-term investment? Read more

Launch of the MEP Cardiovascular Health Group in the European Parliament

During the debate on cardiovascular health held at the European Parliament in Brussels on April 23, the Cardiovascular Health Group was officially launched.

Comprising 16 Members of the European Parliament, the new group represents the European Alliance for Cardiovascular Health (EACH) and will focus on advancing heart health across the EU.

Watch the launch meeting here.

Events

IHI Call Days - call 11
23 June 2025 (Virtual event)

The IHI Call Days for IHI call 11 will take place from 23 to 30 June 2025 online and will include sessions on the individual... Read more

EU-X-CT Public Stakeholder Conference: Final recommendations launch
24 June 2025 (Brussels, hybrid event)

Borders should no longer be barriers in clinical trials. Read more

EUDF: Increasing productivity, competitiveness and resilience by tackling the interplay between...
24 June 2025 (European Parliament, Brussels)

On 24 June, EUDF is hosting a policy-focused event in collaboration with MEP Ignazio Marino, to explore the vital connection... Read more

FACILITATE 2025 Webinar - Return of individual participant data in clinical trials
25 June 2025 (Virtual event)

Organised by Active Citizenship Network, this webinar will bring together key voices from across sectors to explore... Read more

What we are reading

If Horizon Europe’s brand is so valuable, let’s work to protect it
On 04 June 2025 (The Guild)

Ursula von der Leyen’s recent confirmation that the European Union’s research funding programme will remain... Read more

Poland closes innovative therapies gap, but chronic disease reimbursement lags
On 04 June 2025 (Euractiv)

Poland ranks second in the Visegrad region for access to new treatments, yet patients still endure long waits and... Read more

From protection to prevention: The power of immunization for people living with non-communicable...
On 02 June 2025 (IFPMA)

This report outlines how policy- and decision-makers can ensure that all people living with non-communicable diseases... Read more

Ireland launches National Dementia Registry to strengthen care and planning
On 27 May 2025 (Euractiv)

DUBLIN - The Irish government has initiated the development of a National Dementia Registry, a major step in its... Read more

Recommendation Paper on advancing the use of decentralised elements in clinical trials
On 07 May 2025 (DIA)

The expansion of the use of decentralised elements in clinical trials in the European Union is driven by the opportunities... Read more

About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 37 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

Tel: +32 (0)2 626 25 55
E-mail:Communications@efpia.eu